Cargando…

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor

BACKGROUND: EGFR-targeted therapy is an attractive option for head and neck squamous cell carcinoma patients. We have recently reported the use of EGFR inhibitors as an adjunct treatment to enhance HLA-DR expression in tumor cells to improve cancer immunotherapy. Nevertheless, we observed that EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumai, Takumi, Oikawa, Kensuke, Aoki, Naoko, Kimura, Shoji, Harabuchi, Yasuaki, Celis, Esteban, Kobayashi, Hiroya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177691/ https://www.ncbi.nlm.nih.gov/pubmed/25240937 http://dx.doi.org/10.1186/s12967-014-0265-3

Ejemplares similares

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
por: Kumai, Takumi, et al.
Publicado: (2015)

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
por: Hirata-Nozaki, Yui, et al.
Publicado: (2019)

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
por: Hayashi, Ryusuke, et al.
Publicado: (2020)

EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
por: Kumai, T, et al.
Publicado: (2013)

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
por: Kosaka, Akemi, et al.
Publicado: (2021)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)

Removal of Coin Cell Lithium Battery Lodged in the Pediatric Pharyngoesophageal Junction by Rigid Esophagoscopy; a Case Report
por: Ominato, Hisataka, et al.
Publicado: (2022)

19th International Symposium on Epstein–Barr Virus and Associated Diseases, 29–30 July 2021, Asahikawa, Japan
por: Kumai, Takumi, et al.
Publicado: (2022)

Laryngeal recurrence of extranodal NK/T cell lymphoma
por: Kumai, Takumi, et al.
Publicado: (2021)

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
por: Kono, Michihisa, et al.
Publicado: (2022)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress
por: Harabuchi, Yasuaki, et al.
Publicado: (2019)

Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein–Barr Virus Relation
por: Takahara, Miki, et al.
Publicado: (2021)

A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
por: Yajima, Yuki, et al.
Publicado: (2022)

Response to PD‐1 blockade in a patient with mucosal melanoma of the middle ear: Case report
por: Komatsuda, Hiroki, et al.
Publicado: (2020)

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
por: Kono, Michihisa, et al.
Publicado: (2022)

T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy
por: Raber, Patrick L., et al.
Publicado: (2016)

The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study
por: Sato, Ryosuke, et al.
Publicado: (2022)

Regulations of Tumor Microenvironment by Prostaglandins
por: Nie, Jeffrey Z., et al.
Publicado: (2023)

Proton tautomerism for strong polarization switching
por: Horiuchi, Sachio, et al.
Publicado: (2017)

Coexistence of normal and inverse deuterium isotope effects in a phase-transition sequence of organic ferroelectrics
por: Horiuchi, Sachio, et al.
Publicado: (2019)

Tumor suppressor prostaglandin D(2)
por: Maeda, Shingo, et al.
Publicado: (2014)

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
por: Hsieh, Cheng-Han, et al.
Publicado: (2020)

Cerebral Infarction as a Rare Adverse Event of Immune Checkpoint Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma: A Case Series
por: Inoue, Takahiro, et al.
Publicado: (2023)

Prostaglandin E(2)-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment
por: Aoki, Tomohiro, et al.
Publicado: (2017)

Prostaglandin-like material extracted from squamous carcinomas of the head and neck.
por: Bennett, A., et al.
Publicado: (1980)

Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil‐induced autoimmune/inflammatory syndrome
por: Harabuchi, Yasuaki, et al.
Publicado: (2019)

Host Prostaglandin E(2)-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
por: Amano, Hideki, et al.
Publicado: (2003)

Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation
por: Komatsuda, Hiroki, et al.
Publicado: (2022)

Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors
por: Barnes, Precious, et al.
Publicado: (2020)

Sweeter tumors with EGFR
por: Robinson, Richard
Publicado: (2008)

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2023)

Gold Nanoparticles Enhance EGFR Inhibition and Irradiation Effects in Head and Neck Squamous Carcinoma Cells
por: Kashin, Masahiko, et al.
Publicado: (2020)

Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
por: Finetti, Federica, et al.
Publicado: (2020)

Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
por: Imamura, Fumio, et al.
Publicado: (2016)

EGFR Mutations in Head and Neck Squamous Cell Carcinoma
por: Nair, Sindhu, et al.
Publicado: (2022)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts
por: Sharpe, Martyn A., et al.
Publicado: (2023)

A retrospective study of parotid gland tumors at a single institution
por: Suzuki, Shiori, et al.
Publicado: (2022)

Bronchiolar adenoma/ciliated muconodular papillary tumor mixed with adenocarcinoma in situ in the same tumor
por: Uchiyama, Suiha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e1i6493popju07vask7loif3t